Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | SC-CAR4BRAIN |
Trade Name | |
Synonyms | |
Drug Descriptions |
SC-CAR4BRAIN are autologous CD4+ and CD8+ T-lymphocytes engineered to express four chimeric antigen receptors (CARs) that target B7-H3, EGFR, ERBB2 (HER2), and interleukin-13 receptor alpha 2 (IL13Ra2), which potentially induce toxicity in B7-H3, EGFR, ERBB2 (HER2), and IL13Ra2-expressing tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C200272 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
SC-CAR4BRAIN | SC-CAR4BRAIN | 0 | 1 |